Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Summit Therapeu ADR (SMMT)
Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Summit Therapeu ADR 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 USA

P: 650-460-8308

Description:

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,186,065
Enterprise Value, $K 1,031,995
Shares Outstanding, K 697,685
Annual Sales, $ 710 K
Annual Net Income, $ -78,780 K
Last Quarter Sales, $ 220 K
Last Quarter Net Income, $ -21,390 K
60-Month Beta -1.01
% of Insider Shareholders 87.50%
% of Institutional Shareholders 1.59%
Float, K 87,211
% Float 12.50%
Short Volume Ratio 0.52

Growth:

1-Year Return -42.11%
3-Year Return -30.33%
5-Year Return -86.82%
5-Year Revenue Growth -97.85%
5-Year Earnings Growth 45.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 03/09/23
Next Earnings Date 05/10/23
Earnings Per Share ttm -0.81
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 75.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SMMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -83.89%
Return-on-Assets % -30.55%
Profit Margin % -11,095.77
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 1,652.67
Price/Cash Flow N/A
Price/Book 2.78
Book Value/Share 0.66
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar